NaviFUS Corp

ROCO:6872 (Taiwan)  
NT$ 29.50 (-1.01%) Jun 20
At Loss
P/B:
3.97
Market Cap:
NT$ 1.84B ($ 56.84M)
Enterprise V:
NT$ 1.38B ($ 42.57M)
Volume:
106.78K
Avg Vol (2M):
96.05K
Trade In:
Volume:
106.78K
At Loss
Avg Vol (2M):
96.05K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for NaviFUS Corp ( ROCO:6872 ) from 2022 to Jun 20 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. NaviFUS stock (ROCO:6872) PE ratio as of Jun 20 2024 is 0. More Details

NaviFUS Corp (ROCO:6872) PE Ratio (TTM) Chart

To

NaviFUS Corp (ROCO:6872) PE Ratio (TTM) Historical Data

Total 498
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
NaviFUS PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-20 At Loss 2024-04-17 At Loss
2024-06-20 At Loss 2024-04-16 At Loss
2024-06-19 At Loss 2024-04-15 At Loss
2024-06-18 At Loss 2024-04-12 At Loss
2024-06-17 At Loss 2024-04-11 At Loss
2024-06-14 At Loss 2024-04-10 At Loss
2024-06-13 At Loss 2024-04-09 At Loss
2024-06-12 At Loss 2024-04-08 At Loss
2024-06-11 At Loss 2024-04-05 At Loss
2024-06-07 At Loss 2024-04-04 At Loss
2024-06-06 At Loss 2024-04-03 At Loss
2024-06-05 At Loss 2024-04-02 At Loss
2024-06-04 At Loss 2024-04-01 At Loss
2024-06-03 At Loss 2024-03-29 At Loss
2024-05-31 At Loss 2024-03-28 At Loss
2024-05-30 At Loss 2024-03-27 At Loss
2024-05-29 At Loss 2024-03-26 At Loss
2024-05-28 At Loss 2024-03-25 At Loss
2024-05-27 At Loss 2024-03-22 At Loss
2024-05-24 At Loss 2024-03-21 At Loss
2024-05-23 At Loss 2024-03-20 At Loss
2024-05-22 At Loss 2024-03-19 At Loss
2024-05-21 At Loss 2024-03-18 At Loss
2024-05-20 At Loss 2024-03-15 At Loss
2024-05-17 At Loss 2024-03-14 At Loss
2024-05-16 At Loss 2024-03-13 At Loss
2024-05-15 At Loss 2024-03-12 At Loss
2024-05-14 At Loss 2024-03-11 At Loss
2024-05-13 At Loss 2024-03-08 At Loss
2024-05-10 At Loss 2024-03-07 At Loss
2024-05-09 At Loss 2024-03-06 At Loss
2024-05-08 At Loss 2024-03-05 At Loss
2024-05-07 At Loss 2024-03-04 At Loss
2024-05-06 At Loss 2024-03-01 At Loss
2024-05-03 At Loss 2024-02-29 At Loss
2024-05-02 At Loss 2024-02-28 At Loss
2024-04-30 At Loss 2024-02-27 At Loss
2024-04-29 At Loss 2024-02-26 At Loss
2024-04-26 At Loss 2024-02-23 At Loss
2024-04-25 At Loss 2024-02-22 At Loss
2024-04-24 At Loss 2024-02-21 At Loss
2024-04-23 At Loss 2024-02-20 At Loss
2024-04-22 At Loss 2024-02-19 At Loss
2024-04-19 At Loss 2024-02-16 At Loss
2024-04-18 At Loss 2024-02-15 At Loss

NaviFUS Corp (ROCO:6872) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
NaviFUS Corp is a Biotech company providing novel platform solutions for crossing the blood-brain barrier (BBB) for enhanced oncology drug delivery. Its product, the NaviFUS System, is designed to utilize non-invasive ultrasound energy to enable transient and safe enhancement of BBB permeability to facilitate the transport of small or large molecular CNS drugs to target tumor tissue at high precision for better treatment outcomes. Its vision is to cater to CNS disease patients locally and globally by bringing therapeutic ultrasound technology to clinical use.